<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary information extracted from Intel Corporation's
CONSOLIDATED CONDENSED STATEMENTS OF INCOME AND CONSOLIDATED CONDENSED BALANCE
SHEETS and is qualified in its entirety by reference to such financial
statements.
</LEGEND>
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-30-2000
<PERIOD-END>                               JUL-01-2000
<CASH>                                            7308
<SECURITIES>                                      6336
<RECEIVABLES>                                     4333<F2>
<ALLOWANCES>                                         0
<INVENTORY>                                       1607
<CURRENT-ASSETS>                                 20550
<PP&E>                                           24902
<DEPRECIATION>                                   12578
<TOTAL-ASSETS>                                   48520
<CURRENT-LIABILITIES>                             8336
<BONDS>                                            870
                                0
                                          0
<COMMON>                                          7941
<OTHER-SE>                                       28679
<TOTAL-LIABILITY-AND-EQUITY>                     48520
<SALES>                                          16293
<TOTAL-REVENUES>                                 16293
<CGS>                                             6272
<TOTAL-COSTS>                                     6272
<OTHER-EXPENSES>                                  2712<F1>
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  21
<INCOME-PRETAX>                                   7943
<INCOME-TAX>                                      2110
<INCOME-CONTINUING>                               5833
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      5833
<EPS-BASIC>                                       0.87
<EPS-DILUTED>                                     0.83
<FN>
<F2>Item shown net of allowance, consistent with the balance sheet presentation.
<F1>Item consists of research and development, including purchased in-process
research and development, and amortization of goodwill and other
acquisition-related intangibles.
</FN>


</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission